Investors Hangout Stock Message Boards Logo
  • Mailbox
  • Favorites
  • Boards
    • The Hangout
    • NASDAQ
    • NYSE
    • OTC Markets
    • All Boards
  • Whats Hot!
    • Recent Activity
    • Most Viewed Boards
    • Most Viewed Posts
    • Most Posted
    • Most Followed
    • Top Boards
    • Newest Boards
    • Newest Members
  • Blog
    • Recent Blog Posts
    • Recently Updated
    • News
    • Stocks
    • Crypto
    • Investing
    • Business
    • Markets
    • Economy
    • Real Estate
    • Personal Finance
  • Market Movers
  • Interactive Charts
  • Login - Join Now FREE!
  1. Home ›
  2. Stock Message Boards ›
  3. Stock Boards ›
  4. CytoDyn Inc (CYDY) Message Board

Browsing medical literature and found something I

Message Board Public Reply | Private Reply | Keep | Replies (0)                   Post New Msg
Edit Msg () | Previous | Next


Post# of 153887
(Total Views: 706)
Posted On: 11/13/2020 11:48:26 AM
Posted By: dfwl28
Browsing medical literature and found something I worth sharing with cydy folks who want to get smarter.

"...Alcino Silva, a prominent researcher of learning and memory at UCLA and long-time collaborator of Dr. Carmichael, identified a new molecule that enhances learning and memory in mice. This molecule, called “CCR5”, was unexpected for a memory molecule, because its previous function was identified in the immune system . Blocking CCR5 improved learning and memory in a dramatic way in mice. This work was published in the high impact journal Elife.

Second, Drs. Silva and Carmichael reasoned that CCR5 might have an effect in stroke recovery because of how it stimulated memory function. They launched a fully separate and independent set of studies, an orthogonal experiment, to determine if this molecule improved recovery in stroke. Blocking CCR5 did improve stroke recovery in mice in a quite substantial way. CCR5 has a naturally occurring gene mutation in people. This mutation, termed the “delta32” mutation, produces a loss of function in the gene. In a third orthogonal experiment, the Carmichael Lab teamed up with a research group in Israel to determine if patients with this delta32 mutation in CCR5 have better recovery of function after stroke. The findings in mice would predict that they would. This turned out to be the case— patients with the CCR5 mutation recovered better from stroke. A final part of this story is that CCR5 blockers are already developed in medicine as drugs. One such drug is called maraviroc.

https://www.uclahealth.org/neurology/brain-re...ical-trial



(7)
(0)




CytoDyn Inc (CYDY) Stock Research Links


  1.  
  2.  


  3.  
  4.  
  5.  






Investors Hangout

Home

Mailbox

Message Boards

Favorites

Whats Hot

Blog

Settings

Privacy Policy

Terms and Conditions

Disclaimer

Contact Us

Whats Hot

Recent Activity

Most Viewed Boards

Most Viewed Posts

Most Posted Boards

Most Followed

Top Boards

Newest Boards

Newest Members

Investors Hangout Message Boards

Welcome To Investors Hangout

Stock Message Boards

American Stock Exchange (AMEX)

NASDAQ Stock Exchange (NASDAQ)

New York Stock Exchange (NYSE)

Penny Stocks - (OTC)

User Boards

The Hangout

Private

Global Markets

Australian Securities Exchange (ASX)

Euronext Amsterdam (AMS)

Euronext Brussels (BRU)

Euronext Lisbon (LIS)

Euronext Paris (PAR)

Foreign Exchange (FOREX)

Hong Kong Stock Exchange (HKEX)

London Stock Exchange (LSE)

Milan Stock Exchange (MLSE)

New Zealand Exchange (NZX)

Singapore Stock Exchange (SGX)

Toronto Stock Exchange (TSX)

Contact Investors Hangout

Email Us

Follow Investors Hangout

Twitter

YouTube

Facebook

Market Data powered by QuoteMedia. Copyright © 2025. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges).
Analyst Ratings & Earnings by Zacks. RT=Real-Time, EOD=End of Day, PD=Previous Day. Terms of Use.

© 2025 Copyright Investors Hangout, LLC All Rights Reserved.

Privacy Policy |Do Not Sell My Information | Terms & Conditions | Disclaimer | Help | Contact Us